EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 38.4 NZD -0.26% Market Closed
Market Cap: 7.5B NZD
Have any thoughts about
EBOS Group Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
EBOS Group Ltd

Revenue
13.2B AUD
Cost of Revenue
-11.6B AUD
Gross Profit
1.6B AUD
Operating Expenses
-1.2B AUD
Operating Income
482.5m AUD
Other Expenses
-211m AUD
Net Income
271.5m AUD

Margins Comparison
EBOS Group Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
NZ
EBOS Group Ltd
NZX:EBO
7.4B NZD
12%
4%
2%
US
Mckesson Corp
NYSE:MCK
78.9B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
48.9B USD
3%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
48.7B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
29.8B USD
3%
1%
1%
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD
32%
5%
3%
CN
Huadong Medicine Co Ltd
SZSE:000963
66.5B CNY
32%
10%
8%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.9B CNY
11%
3%
1%
CN
Sinopharm Group Co Ltd
HKEX:1099
64.9B HKD
8%
4%
1%
IT
Amplifon SpA
MIL:AMP
5.5B EUR
24%
12%
7%
Country NZ
Market Cap 7.4B NZD
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 78.9B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 48.9B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 48.7B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 29.8B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 9.5B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 66.5B CNY
Gross Margin
32%
Operating Margin
10%
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 60.9B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
1%
Country CN
Market Cap 64.9B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country IT
Market Cap 5.5B EUR
Gross Margin
24%
Operating Margin
12%
Net Margin
7%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
EBOS Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
NZ
EBOS Group Ltd
NZX:EBO
7.4B NZD
11%
4%
13%
8%
US
Mckesson Corp
NYSE:MCK
78.9B USD
-105%
4%
27%
18%
US
Cencora Inc
NYSE:COR
48.9B USD
258%
2%
23%
17%
US
Amerisourcebergen Corp
LSE:0HF3
48.7B USD
258%
2%
23%
17%
US
Cardinal Health Inc
NYSE:CAH
29.8B USD
-37%
3%
26%
17%
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD
9%
3%
8%
5%
CN
Huadong Medicine Co Ltd
SZSE:000963
66.5B CNY
15%
9%
18%
14%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.9B CNY
6%
2%
9%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
64.9B HKD
12%
2%
15%
7%
IT
Amplifon SpA
MIL:AMP
5.5B EUR
14%
4%
11%
6%
Country NZ
Market Cap 7.4B NZD
ROE
11%
ROA
4%
ROCE
13%
ROIC
8%
Country US
Market Cap 78.9B USD
ROE
-105%
ROA
4%
ROCE
27%
ROIC
18%
Country US
Market Cap 48.9B USD
ROE
258%
ROA
2%
ROCE
23%
ROIC
17%
Country US
Market Cap 48.7B USD
ROE
258%
ROA
2%
ROCE
23%
ROIC
17%
Country US
Market Cap 29.8B USD
ROE
-37%
ROA
3%
ROCE
26%
ROIC
17%
Country US
Market Cap 9.5B USD
ROE
9%
ROA
3%
ROCE
8%
ROIC
5%
Country CN
Market Cap 66.5B CNY
ROE
15%
ROA
9%
ROCE
18%
ROIC
14%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 60.9B CNY
ROE
6%
ROA
2%
ROCE
9%
ROIC
5%
Country CN
Market Cap 64.9B HKD
ROE
12%
ROA
2%
ROCE
15%
ROIC
7%
Country IT
Market Cap 5.5B EUR
ROE
14%
ROA
4%
ROCE
11%
ROIC
6%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top